What are the anesthetic implications for patients with aortic (aortic valve) sclerotic disease?

Anesthetic Management of Aortic Valve Sclerotic Disease

Primary Recommendation

Patients with aortic sclerosis/stenosis can safely undergo noncardiac surgery with appropriate hemodynamic monitoring and optimization, avoiding prophylactic valve intervention in asymptomatic patients, but requiring meticulous attention to maintaining preload, avoiding tachycardia, and preventing hypotension throughout the perioperative period. 1

---

Preoperative Risk Stratification

Severity Assessment

• All patients require echocardiographic quantification of stenosis severity, left ventricular function, and pulmonary artery pressures before proceeding 1
• Asymptomatic patients with severe AS (valve area <1.0 cm²) and normal LVEF can undergo moderate-risk elective noncardiac surgery with appropriate monitoring 1
• Symptomatic severe AS requires valve intervention before elective noncardiac surgery to avoid prohibitive perioperative mortality 1

Risk Factors for Adverse Outcomes

• Predictors of 30-day mortality and MI include: high-risk surgery (OR 7.3), symptomatic severe AS (OR 2.7), coexisting moderate-severe mitral regurgitation (OR 9.8), and pre-existing CAD (OR 2.7) 1
• Emergency surgery in uncorrected severe AS carries significantly higher risk but may be necessary 1

---

Hemodynamic Goals: The Critical Triad

Maintain Preload

• Adequate preload is essential - these patients have hypertrophied, non-compliant ventricles that depend on atrial kick and adequate filling 1
• Avoid excessive diuresis or fluid restriction preoperatively 1
• Monitor central venous pressure or use TEE to guide fluid management 1

Avoid Tachycardia

• Maintain normal sinus rhythm and heart rate - tachycardia reduces diastolic filling time and coronary perfusion 1
• Tachycardia combined with hypotension can precipitate myocardial ischemia, arrhythmias, and cardiac failure 1
• Treat atrial fibrillation aggressively with rate control or cardioversion 1

Prevent Hypotension

• Systemic hypotension is poorly tolerated and can lead to decreased coronary perfusion pressure, ischemia, and death 1
• Use phenylephrine or norepinephrine to maintain blood pressure in patients without significant CAD 1
• Avoid vasodilators that cause precipitous drops in systemic vascular resistance 1

---

Anesthetic Technique Selection

General Anesthesia Considerations

• General anesthesia is well tolerated when agents are chosen to maintain sinus rhythm and normotension 1
• Avoid agents causing significant myocardial depression or vasodilation 1
• Induction of general anesthesia typically decreases cardiac index and stroke volume index 2
• Selected patients with severe AS can undergo procedures under general anesthesia at reasonably low risk with careful monitoring 3

Regional Anesthesia Approach

• Regional anesthesia may be preferable for peripheral procedures as it avoids the hemodynamic instability of general anesthesia induction 3
• Neuraxial techniques (spinal/epidural) can be used but require extreme caution to avoid sympathetic blockade and hypotension 1
• Regional anesthesia is contraindicated with anticoagulation (INR ≥1.5), platelet count <50×10⁹/L, or infection at injection site 4
• Local anesthesia with sedation is associated with lower vasoactive agent use, shorter ICU stays, and fewer respiratory/renal complications compared to general anesthesia 1

Critical Caveat

• Avoid the combination of general anesthesia and neuraxial block as recommended by guidelines 4

---

Intraoperative Monitoring Requirements

Mandatory Monitoring

• Invasive arterial pressure monitoring is required in one or more sites 1
• Arterial line should be placed proximal to any planned aortic cross-clamping 1
• Central venous pressure monitoring or pulmonary artery catheter placement is reasonable for optimization of loading conditions 1

Transesophageal Echocardiography

• TEE is reasonable for all open surgical repairs and can guide hemodynamic management 1
• TEE allows real-time assessment of ventricular filling, contractility, and valve function 1
• Particularly useful for continuous optimization of loading conditions in severe AS 1

Postoperative Monitoring

• Continue intensive monitoring for 48-72 hours postoperatively as fluid shifts and hemodynamic changes persist 1
• Patients with severe left-sided stenosis requiring emergency surgery should remain in intensive monitoring settings 1

---

Pharmacologic Management During Surgery

Inotropic Support

• Dobutamine increases cardiac index primarily through heart rate elevation rather than stroke volume augmentation in AS patients 2
• Dobutamine's effect on stroke volume is highly variable and associated with baseline LVEF - higher preoperative EF predicts better response 2
• Consider inotropic support for patients with depressed systolic function 1

Fluid Management

• Fluid boluses increase stroke volume index but at the cost of increased pulmonary capillary wedge pressure 2
• PCWP increases most in patients with larger left atrial volume index 2
• Judicious fluid administration prevents pulmonary edema while maintaining adequate preload 1

Vasopressor Selection

• Phenylephrine or norepinephrine are preferred to maintain systemic vascular resistance and coronary perfusion 1
• Avoid pure vasodilators unless treating acute pulmonary edema under invasive monitoring 1

---

Special Considerations

Emergency Surgery Context

• Emergency noncardiac surgery may be necessary despite uncorrected severe AS 1
• Management requires cardiovascular anesthesiologist involvement 1
• Balloon aortic valvuloplasty is NOT recommended as a bridge to noncardiac surgery in asymptomatic patients 1
• If preoperative AS correction is needed, proceed directly to aortic valve replacement rather than balloon valvuloplasty 1

Temperature Monitoring

• Monitor temperature in at least 2 locations: brain/core (esophageal, tympanic, nasopharynx) and visceral (bladder/rectal) 1

Pacing Considerations

• Temporary transvenous pacing should be available given risk of atrioventricular block (16% incidence in TAVI procedures) 5

---

Common Pitfalls to Avoid

• Do NOT perform prophylactic valve replacement before noncardiac surgery in asymptomatic severe AS - risk-benefit favors proceeding with hemodynamic optimization 1
• Do NOT use balloon valvuloplasty as bridge to noncardiac surgery - it provides only short-term palliation with high complication rates 1
• Do NOT allow hypovolemia - these patients are preload-dependent 1
• Do NOT permit tachycardia - it compromises diastolic filling and coronary perfusion 1
• Do NOT use excessive preload reduction - can depress cardiac output and systemic pressure in hypertrophied ventricles 1
• Do NOT combine general and neuraxial anesthesia 4

---

Outcome Data

• Recent data show 30-day mortality of 2.1% in AS patients undergoing noncardiac surgery versus 1.0% in matched controls 1
• This represents significant improvement from historical 13% mortality rates with modern anesthetic techniques 1
• Hospital mortality for TAVI procedures is 11%, below predicted surgical risk scores 5
• Selected patients can undergo procedures at reasonably low risk with appropriate monitoring 3